CSL Ltd (CSLLY)
91.71
-1.20
(-1.29%)
USD |
OTCM |
Nov 14, 16:00
CSL 1 Year Total Returns (Daily): 10.70% for Nov. 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 14, 2024 | 10.70% |
November 13, 2024 | 16.78% |
November 12, 2024 | 16.85% |
November 11, 2024 | 18.86% |
November 08, 2024 | 18.93% |
November 07, 2024 | 20.75% |
November 06, 2024 | 18.34% |
November 05, 2024 | 20.44% |
November 04, 2024 | 19.31% |
November 01, 2024 | 25.67% |
October 31, 2024 | 28.81% |
October 30, 2024 | 30.86% |
October 29, 2024 | 32.40% |
October 28, 2024 | 33.18% |
October 25, 2024 | 32.71% |
October 24, 2024 | 31.64% |
October 23, 2024 | 31.77% |
October 22, 2024 | 37.59% |
October 21, 2024 | 39.88% |
October 18, 2024 | 36.27% |
October 17, 2024 | 35.96% |
October 16, 2024 | 33.29% |
October 15, 2024 | 34.39% |
October 14, 2024 | 34.56% |
October 11, 2024 | 25.17% |
Date | Value |
---|---|
October 10, 2024 | 22.29% |
October 09, 2024 | 23.87% |
October 08, 2024 | 24.85% |
October 07, 2024 | 23.32% |
October 04, 2024 | 26.74% |
October 03, 2024 | 27.96% |
October 02, 2024 | 28.60% |
October 01, 2024 | 24.96% |
September 30, 2024 | 24.01% |
September 27, 2024 | 25.30% |
September 26, 2024 | 24.80% |
September 25, 2024 | 22.65% |
September 24, 2024 | 23.84% |
September 23, 2024 | 24.08% |
September 20, 2024 | 18.91% |
September 19, 2024 | 19.65% |
September 18, 2024 | 18.72% |
September 17, 2024 | 18.65% |
September 16, 2024 | 18.65% |
September 13, 2024 | 18.01% |
September 12, 2024 | 18.77% |
September 11, 2024 | 18.02% |
September 10, 2024 | 18.42% |
September 09, 2024 | 18.27% |
September 06, 2024 | 17.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-23.85%
Minimum
Nov 03 2022
73.97%
Maximum
Feb 19 2020
8.29%
Average
3.27%
Median
1 Year Total Returns (Daily) Benchmarks
Alterity Therapeutics Ltd | -55.51% |
Kazia Therapeutics Ltd | -28.78% |
Immutep Ltd | 12.97% |
Opthea Ltd | 96.51% |
Mesoblast Ltd | 363.9% |